Brief: Lipigon Pharmaceuticals Q1 Operating Loss Narrows To SEK 6.8 Mln
25/05/2023 07:55
May 25 (Reuters) - Lipigon Pharmaceuticals AB LPGO.ST :
* Q1 OPERATING LOSS SEK 6.8 MILLION VERSUS LOSS SEK 9.0
MILLION
YEAR AGO
Source text for Eikon: ID:nBQN7y1TN1
Further company coverage: LPGO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Lipigon Pharmaceuticals AB
See all newsBrief: Nasdaq To Delist Lipigon Pharmaceuticals From First North Growth Market
Brief: Lipigon Expected To Be Removed From Trading On Nasdaq Stockholm On May 18
Brief: Lipigon Proposes To Delist Company From Nasdaq First NGM
Brief: Lipigon Pharmaceuticals Oct-Dec Oper Loss At SEK 7.2 Mln
Brief: Lipigon Pharmaceuticals Aims To Reduce Cost Base By Two-Thirds